RadioRx's Series A - III Round

RadioRx raised a round of funding on February 29, 2012. Investors include InterWest Partners.

RadioRx discovers and develops compounds sourced and adapted from the aerospace industry for treating cancer and other indications. RadioRx’s lead compound is called RRx-001, a structurally unique p…

Articles about RadioRx's Series A - III Round: